$CYCA is a global leader in the design, manufacturing and

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
197
$CYCA is a global leader in the design, manufacturing and marketing of advanced communications systems for the most demanding applications including first responders worldwide. Increasing demand is moving the company to opening new manufacturing operations now.

Latest news:

CYTTA Corp Retains US Based Manufacturer Specializing in Advanced Manufacturing Solutions

Las Vegas , Sept. 14, 2020 (GLOBE NEWSWIRE) -- -- Cytta Corp (OTCPINK: CYCA) Cytta announces an agreement that will enable us to achieve full scalability in our supply chain. The Company has finalized negotiations with a very well-respected US based manufacturer with the expertise, production capabilities and quality controls to enable Cytta to scale its IGAN Fusion and SUPR Stream production to meet rapidly growing demand.

Propelled by the success and customer satisfaction of our early SUPR and IGAN installations, Cytta is experiencing rapid growth in product demand. Rapid scalability in all aspects of our ongoing operations is mission critical. Achieving scale in manufacturing and maintaining inventory will support this growth and shorten the sales cycle.

Our chosen partner is well-recognized for its historically advanced engineering, design, and manufacture of complex electronic and electromechanical devices. Both IGAN Fusion and SUPR Stream will utilize their specific expertise with sophisticated printed circuit card assemblies, sub-assemblies, full product assemblies, and cable/wire harnesses. Our chosen manufacturer also has strong customer relationships with many of the world’s leading OEMs across complementary military and industrial markets.

“We are pleased with the robust manufacturing platform we will now be able to utilize to design and manufacture IGAN and SUPR systems. Our partner has become a trusted partner to many leading businesses around the world, and has a strong reputation for delivering high-quality, complex manufacturing solutions,” said Gary Campbell, CEO of Cytta Corp. “Adding their considerable expertise and capabilities to Cytta’s paradigm shifting technologies, concepts and systems will move our Company to a whole new level.”

Previously, units were manufactured on an 'as sold' basis to control costs. While this allowed us to conserve cash, it limited our ability to scale as we did not maintain inventory of finished product. With the successful completion of our recent round of equity financing, Cytta is now able to complete the process of becoming a fully reporting, 1934 Act company, manufacture inventory to fulfill the demand of our pipeline, invest in sales force expansion, marketing, product development and investor relations.

About Us

Cytta Corp (OTCPINK: CYCA) brings technology from military to enterprise. Our proprietary SUPR Stream, the most powerful codec in the world, is the technology at the core of our products, designed specifically for streaming and storing HD, 4K, and higher resolution video. The IGAN Matrix seamlessly streams and stores all relevant video and audio during emergency situations. This creates real-time video and audio situational awareness for police, firefighters, first responders, industry, military and their command centers.

Cytta Corp products work in size, weight, and power-constrained (SWaP) operating environments, and evolved through use in the military by meeting the need to stream multiple HD, 4K, and 4K+ video feeds with ultra-low latency, bandwidth, and power consumption. Cytta is taking this streaming, storage, and transfer technology to enterprises that would like to send more high-quality videos with fewer resources. Cytta manufactures all their products in the USA. For more information, please visit Cytta.com and/or the Cytta Video Channel on YouTube for our new Video highlighting the emergency rescue applications of the IGAN Fusion and SUPR Stream.

Safe Harbor Statement / Forward-Looking Statements

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties, the impact of actions and events involving key customers, vendors, lenders, competitors, and other risks. Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will", and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.


Cytta Corp
http://www.cytta.com
Office (855) 511-4426
info@cytta.com

Gary Campbell, CEO
Direct (702) 900-7022
Gary@cytta.com

Michael Chermak, Chief Administrative and Investment Officer
Cell: (619) 977-7203
Chermak@Cytta.com

Corporate Communications Contact:
Complete Advisory Partners
Office: (586) 228-2290
Cell: (586) 801-9002
Email: CapInc@comcast.net
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Gentherm's Q2 2025 Results Highlight Strong Performance & Future

Updated Category News Views 132

Gentherm's Financial Performance for Second Quarter 2025 Gentherm, a global innovator in thermal management technologies, reported outstanding financial outcomes for the second quarter of 2025. The company's revenue reached $375 million, underscoring its strength in the automotive sector, particularly within Climate and Comfort Solutions. Record Achievements and New...

Continue Reading
DEALMining Surpasses 6.8 Million Users with Exciting Rewards

Updated Category News Views 237

DEALMining Achieves Major User Milestone In a significant accomplishment, DEALMining has proudly announced that its user base has exceeded 6.8 million globally, marking its status as one of the fastest-growing compliant cloud mining platforms in the world. This impressive growth showcases DEALMining's successful outreach across more than 200 countries and regions, as the...

Continue Reading
Investigation Launched into Aehr Test Systems for Investors' Losses

Updated Category News Views 218

Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...

Continue Reading
Vivoryon Therapeutics to Share Insights on 2024 Performance

Updated Category News Views 176

Vivoryon Therapeutics N.V. Set to Report Financial Outcomes Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) is gearing up to unveil its financial results for the entirety of 2024, along with insights into its operational achievements. The highly anticipated announcement is scheduled for April 29, 2025, aiming to shed light on the company’s progress in...

Continue Reading
Navigating Economic Trends: Insights for Savvy Investors

Updated Category News Views 110

Understanding the Economic Climate In finance, a stable economy is often described as a "Goldilocks" economy, where conditions are ideal for investments to flourish. Lately, we have witnessed an economy that consistently surpasses expectations, putting worries about downturns to rest. The Search for Economic Balance Investors are keen to find that sweet spot where...

Continue Reading